Electra Therapeutics

Drug Discovery · South San Francisco, CA · Founded 2018 · Privately Held (backing)

Operator of a biotechnology company intended for the treatment of immunological diseases and cancer. Electra Therapeutics is based in South San Francisco, CA and was founded in 2018. It was valued at $479 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $301 million across 2 recorded rounds; the latest was an $183 million Series C in Oct 2025.

PMV mark · valuation
$479.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$301.0M
Last round
Later Stage VC (Series C)
Oct 2025
What is Electra Therapeutics worth?
$479.0MPrivateMarketView mark · Oct 2026

Valued at $479.0M at its later-stage round, Oct 2025. Nothing has traded since.

Free account
More of Electra Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Electra Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Electra Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
Oct 2025Later Stage VC (Series C)$183.0M▮
Feb 2022Early Stage VC (Series B)$84.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Electra Therapeutics valuation

Electra Therapeutics was valued at $479 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Electra Therapeutics raised?

Electra Therapeutics has raised $301 million across 2 recorded rounds since 2022. The largest was an $84 million Series B in Feb 2022; the most recent was an $183 million Series C in Oct 2025.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Rivus Pharmaceuticals ($489 million), CORXEL Pharmaceuticals ($475 million) and Diagonal Therapeutics ($459 million).

How Electra Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Electra Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Electra Therapeutics

What is Electra Therapeutics worth?
Electra Therapeutics is valued at $479.0M as of Oct 2026. Valued at $479.0M at its later-stage round, Oct 2025. Nothing has traded since.
How much has Electra Therapeutics raised?
Electra Therapeutics has raised $301.0M in total funding across 2 recorded rounds.
When did Electra Therapeutics last raise?
Electra Therapeutics last raised in Oct 2025 (Later Stage VC (Series C)), raising $183.0M.